Literature DB >> 22796326

Current views on calcium phosphate osteogenicity and the translation into effective bone regeneration strategies.

Y C Chai1, A Carlier, J Bolander, S J Roberts, L Geris, J Schrooten, H Van Oosterwyck, F P Luyten.   

Abstract

Calcium phosphate (CaP) has traditionally been used for the repair of bone defects because of its strong resemblance to the inorganic phase of bone matrix. Nowadays, a variety of natural or synthetic CaP-based biomaterials are produced and have been extensively used for dental and orthopaedic applications. This is justified by their biocompatibility, osteoconductivity and osteoinductivity (i.e. the intrinsic material property that initiates de novo bone formation), which are attributed to the chemical composition, surface topography, macro/microporosity and the dissolution kinetics. However, the exact molecular mechanism of action is unknown. This review paper first summarizes the most important aspects of bone biology in relation to CaP and the mechanisms of bone matrix mineralization. This is followed by the research findings on the effects of calcium (Ca²⁺) and phosphate (PO₄³⁻) ions on the migration, proliferation and differentiation of osteoblasts during in vivo bone formation and in vitro culture conditions. Further, the rationale of using CaP for bone regeneration is explained, focusing thereby specifically on the material's osteoinductive properties. Examples of different material forms and production techniques are given, with the emphasis on the state-of-the art in fine-tuning the physicochemical properties of CaP-based biomaterials for improved bone induction and the use of CaP as a delivery system for bone morphogenetic proteins. The use of computational models to simulate the CaP-driven osteogenesis is introduced as part of a bone tissue engineering strategy in order to facilitate the understanding of cell-material interactions and to gain further insight into the design and optimization of CaP-based bone reparative units. Finally, limitations and possible solutions related to current experimental and computational techniques are discussed.
Copyright © 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796326     DOI: 10.1016/j.actbio.2012.07.002

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  48 in total

Review 1.  Biomaterials for Bone Regenerative Engineering.

Authors:  Xiaohua Yu; Xiaoyan Tang; Shalini V Gohil; Cato T Laurencin
Journal:  Adv Healthc Mater       Date:  2015-04-07       Impact factor: 9.933

2.  Smart scaffolds: the future of bioceramic.

Authors:  Guy Daculsi
Journal:  J Mater Sci Mater Med       Date:  2015-03-17       Impact factor: 3.896

Review 3.  3D Printing of Calcium Phosphate Ceramics for Bone Tissue Engineering and Drug Delivery.

Authors:  Ryan Trombetta; Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Ann Biomed Eng       Date:  2016-06-20       Impact factor: 3.934

4.  Novel potential scaffold for periodontal tissue engineering.

Authors:  Raquel Osorio; Camilo Andrés Alfonso-Rodríguez; Estrella Osorio; Antonio L Medina-Castillo; Miguel Alaminos; Manuel Toledano-Osorio; Manuel Toledano
Journal:  Clin Oral Investig       Date:  2017-02-18       Impact factor: 3.573

Review 5.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

6.  Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.

Authors:  Mei Li; Weidan Wang; Ye Zhu; Yao Lu; Peng Wan; Ke Yang; Yu Zhang; Chuanbin Mao
Journal:  Acta Biomater       Date:  2018-07-17       Impact factor: 8.947

7.  Effect of scaffold microarchitecture on osteogenic differentiation of human mesenchymal stem cells.

Authors:  Ameya Phadke; YongSung Hwang; Su Hee Kim; Soo Hyun Kim; Tomonori Yamaguchi; Koichi Masuda; Shyni Varghese
Journal:  Eur Cell Mater       Date:  2013-01-18       Impact factor: 3.942

8.  PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment.

Authors:  Tao Wu; Lei Tan; Ning Cheng; Qi Yan; Yu-Feng Zhang; Chuan-Jun Liu; Bin Shi
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-01-08       Impact factor: 7.328

9.  Mapping calcium phosphate activated gene networks as a strategy for targeted osteoinduction of human progenitors.

Authors:  Jeroen Eyckmans; Scott J Roberts; Johanna Bolander; Jan Schrooten; Christopher S Chen; Frank P Luyten
Journal:  Biomaterials       Date:  2013-03-26       Impact factor: 12.479

10.  Modulation of Host Osseointegration during Bone Regeneration by Controlling Exogenous Stem Cells Differentiation Using a Material Approach.

Authors:  Xiaohua Yu; Liping Wang; Zengmin Xia; Li Chen; Xi Jiang; David Rowe; Mei Wei
Journal:  Biomater Sci       Date:  2014-02-01       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.